Apotex Pays Out Over US Price-Fixing Claims

Deal Over Pravastatin Includes $24.1m Fine And Deferred Prosecution Agreement

Apotex
Apotex has settled US price-fixing allegations over pravastatin • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Legal & IP

More from Generics Bulletin